BridgeBio Pharma: Funding, Investors & Team (Oct 2026)
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.
BridgeBio Pharma has raised $1.3B across 2 funding rounds on record, the most recent an undisclosed round of $500M announced in Feb 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BridgeBio Pharma Company Profile and Key Stats
Latest funding round on record: Feb 2025.
BridgeBio Pharma Funding Rounds
BridgeBio Pharma raised $750M in a Post-IPO Debt announced in Nov 2021.
3.3 years later, an undisclosed round of $500M was announced in Feb 2025.
BridgeBio Pharma Founders and Leadership Team
Contact details for the BridgeBio Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →BridgeBio Pharma Funding Compared to Other Biotechnology Startups
BridgeBio Pharma's latest round of $500M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BridgeBio Pharma in Biotechnology and Palo Alto
Companies Similar to BridgeBio Pharma
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
BridgeBio Pharma Funding FAQs
What does BridgeBio Pharma do?
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.
How much funding has BridgeBio Pharma raised?
BridgeBio Pharma has raised $1.3B across 2 rounds on record. The most recent is an undisclosed round of $500M announced in Feb 2025.
When did BridgeBio Pharma last raise funding?
BridgeBio Pharma's most recent funding round on record is an undisclosed round of $500M, announced in Feb 2025.
Who founded BridgeBio Pharma?
FundedIQ lists Neil Kumar (Founder) at BridgeBio Pharma.
Where is BridgeBio Pharma headquartered?
BridgeBio Pharma is based in Palo Alto, California, United States.
How many employees does BridgeBio Pharma have?
BridgeBio Pharma is in the 251-500 employee band.
How does BridgeBio Pharma's funding compare to other Biotechnology startups?
BridgeBio Pharma's latest round of $500M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BridgeBio Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BridgeBio Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.